五月 2026
bioconcept.com
全球排名
- -
国家/地区排名
- -
品类排名
- -
显示 Similarweb 估计数据。
关联 GA4,公开验证您的网站指标
与您的成功同步
绑定 Google Analytics,验证您网站的流量及用户参与度指标
跳出率
- -
每次访问页数
- -
平均访问时长
- -
- 公司
- - -
- 行业
- - -
bioconcept.com的 10 大竞争对手
在 五月 2026 与 bioconcept.com 相似的前 10 名网站,按关键字流量、受众定位和市场重叠方面与 bioconcept.com 的关联性排名
Dengue IgG Capture ELISA E-DEN02G Please note these products are not for sale or distribution in the United States and may not be available in all countries worldwide. Please contact Inverness Medical or your local Panbio distributor to determine availability. Product Overview The Panbio Dengue IgG Capture ELISA is for the qualitative detection of IgG antibodies to dengue virus (serotypes 1, 2, 3 and 4) in serum. This test is intended as an aid in the clinical laboratory diagnosis of secondary dengue virus infection, and can be used in conjunction with the Panbio Dengue IgM Capture ELISA for the presumptive differentiation between primary and secondary infection. The Panbio Dengue IgG Capture ELISA offers an alternative to the HAI assay as an aid in the serological diagnosis of secondary dengue infections. The IgG cut-off is set to detect the high levels of IgG present in secondary infection. As an aid in the diagnosis of secondary dengue For use in endemic dengue regions Use with the Dengue IgM Capture ELISA to detect and distinguish primary and secondary dengue with a high degree of confidence. Quick Info Excellent performance Standardised method Total incubation time 2 hr 10 min Break-apart wells Ready-to-use colour coded reagents Compatible with standard microplate technology Use in conjunction with E-DEN01M to differentiate primary and secondary infection 96 tests Performance Dengue IgM Capture and Dengue IgG Capture ELISA serological sensitivity and specificity1 Serological sensitivity IgM 95% CI* IgG 95% CI* Primary dengue 54/57 (94.7%) 85.4-98.91% N/A N/A Secondary dengue2 64/115 (55.7%)3 46.6-64.7% 52/54 (96.3%) 73.8-93.6% Serological specificity IgM 95% CI* IgG 95% CI Negatives 83/83 (100%) 95.7 - 100 % 125/125 (100%) 97.1-100% Primary dengue N/A 95.7 - 100 % 32/35 (91.4%) 76.9-98.2% This data has been extracted from the Dengue IgM Capture and Dengue IgG Capture ELISA Instructions for Use. Samples positive for secondary dengue infection by HAI (titre
- 公司
- - -
- 行业
- - -
跳出率
46.77%
每次访问页数
1.68
平均访问时长
00:00:44
相似度评分
100%Get more information about the upcoming conferences that KBI Biopharma will be attending.
跳出率
33.69%
每次访问页数
11.26
平均访问时长
00:10:40
carter pharmaceutical consulting inc. is a canadian company, providing consulting, formulation optimization, technology transfer and process troubleshooting services in the areas of solid oral dosage form cmo, fluid bed granulation, manufacturing and training. we are also now pleased to offer non-gmp development trial services in our new, small-scale laboratory.
- 公司
- - -
- 行业
- - -
全球排名
- -
国家/地区排名
- -
品类排名
- -
跳出率
- -
每次访问页数
- -
平均访问时长
- -
bioconcept.com在 五月 2026 的前五名竞争对手是:captisol.com、wolfelabs.com、kbibiopharma.com、carterpharmaceuticalconsulting.com等。
根据 Similarweb 的月访问量数据,bioconcept.com 在 五月 2026 的头号竞争对手是 captisol.com。与 bioconcept.com 相似度排名第二的网站是 wolfelabs.com,排名第三的是 kbibiopharma.com。
在 五月 2026,carterpharmaceuticalconsulting.com 被评为与 bioconcept.com 相似度第四高的网站, 位居第五。
进入前十名榜单的其他五家竞争对手分别是 、、、 和 。
